We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CUBT market cap is 14.45M. The company's latest EPS is USD -0.0064 and P/E is -3.13.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5k | -305k | -5.01M | -4.44M | -1.93M |
| Net Income | 332k | 75k | -18.82M | -5.69M | -5.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40k | 303k | 2.41M | 2.09M | 2.6M |
| Total Liabilities | 397k | 429k | 730k | 4.49M | 5.75M |
| Total Equity | -357k | -126k | -16.36M | -20.53M | -3.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -213k | -1.6M | -1.54M | -486k |
| Investing | N/A | -12k | -22k | -77k | -14k |
| Financing | N/A | 386k | 2.14M | 1M | 498k |
| Market Cap | 14.45M |
| Price to Earnings Ratio | -3.13 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 200 |
| Price to Book Ratio | -5.75 |
| Dividend Yield | - |
| Shares Outstanding | 903.26M |
| Average Volume (1 week) | 211.84k |
| Average Volume (1 Month) | 115.87k |
| 52 Week Change | -51.52% |
| 52 Week High | 0.04 |
| 52 Week Low | 0.0013 |
| Spread (Intraday) | 0 (19.38%) |
| Company Name | Curative Biotechnology Inc (PK) |
| Address |
1825 nw corporate blvd., #110 boca raton, florida 33431 |
| Website | https://curativebiotech.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
